Backed by science and real results, Swiss Medica is leading the way in regenerative stem cell therapies with personalized treatments that go beyond symptom management to restore function and quality ...

New medical discoveries show that stem cell treatment may help patients cope with both bone problems and brain diseases. Recent studies have also shown that stem cell therapy could reduce heart ...

Autoimmune diseases occur when the body's immune system mistakenly attacks healthy cells, creating chronic inflammation and long-term damage. Conventional treatment simply targets symptoms ...

The advance has been published in Stem Cell Research & Therapy (Springer Nature Group ... tissue damage and support healing. This new route of administration avoids systemic circulation and ...

Read the paper: Phase I/II trial of iPS-cell-derived dopaminergic cells for Parkinson ... medicine could offer an alternative route to effective treatment. Read the paper: Phase I trial of ...

Researchers at Memorial Sloan Kettering Cancer Center (MSK) have announced progress on that front — they have developed a new therapy that uses stem cells to treat advanced Parkinson’s.

It's exciting to be part of a team that works to better understand how to control stem cell behavior, which could be leveraged for therapies focused on tissue regeneration or disease treatment." ...

Both clinical trials establish the safety of allogeneic (non-self) transplantation of stem cell-derived cell products for the treatment of Parkinson's disease. Some limitations are noted ...

The phase I clinical trials showed stem cell transplants for Parkinson’s disease appear to be safe and might restore dopamine-producing brain cells.

A stem cell–based therapy initially developed at Memorial Sloan Kettering Cancer Center (MSK) may lead to a new treatment for advanced Parkinson's disease, according to results from a phase 1 ...